Hair Removal With Vaniqa
Vaniqa hair removal is a prescription-only topical cream that has been FDA-approved for reducing and inhibiting the growth of unwanted facial hair. The active ingredient in Vaniqa is eflornithine hydrochloride, which has been used to treat African sleeping sickness and certain cancers. Vaniqa works by inhibiting an enzyme that is needed for cell reproduction and other cell functions necessary for hair growth.
Continue to use Vaniqa even if you do not see immediate results. Reduction in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment with Vaniqa should be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment with Vaniqa.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most common side effects persist or become bothersome: Redness; skin tingling; temporary stinging or burning. Seek medical attention right away if any of these side effects occur: Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bleeding or irritation of the skin.
Hair growth cells and cancer cells share some interesting characteristics: rapidly dividing with multiple potentials for differentiation. This is one reason chemotherapy and radiation can result in hair loss: they disrupt the same kinds of cellular activity . It has been theorized that some cancer drugs may be used to induce a controlled amount of hair loss or reduction. Vaniqa’s active ingredient, eflornithine hydrochloride, has antitumor activity. It is the first commercially available topical preparation to come out of this sort of research.
In clinical trials, one out of three women using Vaniqa had significantly less or no facial hair growth at the application site after 24 weeks of therapy. Another 26 percent showed some improvement, while 42 percent reported no change or increased hair growth. Vaniqa users also said they spent significantly less time removing, treating, or concealing their facial hair.
Vaniqa is a prescription hair reduction cream; its active ingredient, Eflornithine, was originally developed as a cancer medication. Unfortunately, doctors found no significant effects on cancer, but discovered a number of surprising uses for the drug, as a treatment for African sleeping sickness and you guess it, hair reduction. Vaniqa cream is not to be confused with a depilatory; it does not remove hair. It is an enzyme inhibitor that simply retards hair growth. Within the first 4-6 weeks most Vaniqa users see a noticeable reduction in the amount of unwanted facial hair.
If you have tried hair removal creams from the three brands mentioned above without the results that you were looking for, then Vaniqa may be a good option. Vaniqa is a prescription hair removal cream. However, it is designed to remove that annoying facial hair that you have always wanted to get rid of. The good news is that Vaniqa is FDA approved, as well as dermatologist recommended.
